ProShares Ultra NASDAQ Biotechnology
37 hedge funds and large institutions have $16M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
Holders
37
Holders Change
+5
Holders Change %
+15.63%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
6
Reduced
10
Closed
6
Calls
$10.3M
Puts
$3.75M
Net Calls
+$6.57M
Net Calls Change
+$6.17M
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$2.59M |
2 |
OMC
2
Old Mission Capital
Chicago,
Illinois
|
$3.3M |
3 |
![]()
3
Simplex Trading
Chicago,
Illinois
|
$596K |
4 |
HF
4
HRT Financial
New York
|
$536K |
5 |
5
Jane Street
New York
|
$518K |